Related references
Note: Only part of the references are listed.Cardiac manifestations of Anderson-Fabry disease in children and adolescents
Christoph Kampmann et al.
ACTA PAEDIATRICA (2008)
Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa
D. A. Hughes et al.
HEART (2008)
Onset and progression of the Anderson-Fabry disease related cardiomyopathy
Christoph Kampmann et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
Females with Fabry disease frequently have major organ involvement: Lessons from the Fabry Registry
William R. Wilcox et al.
MOLECULAR GENETICS AND METABOLISM (2008)
Nephropathy in males and females with Fabry disease: cross-sectional description of patients before treatment with enzyme replacement therapy
Alberto Ortiz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Characterization of Fabry Disease in 352 Pediatric Patients in the Fabry Registry
Robert J. Hopkin et al.
PEDIATRIC RESEARCH (2008)
Antiproteinuric therapy and Fabry nephropathy:: Sustained reduction of proteinuria in patients receiving enzyme replacement therapy with agalsidase-β
Hindia Tahir et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Weekly enzyme replacement therapy may slow decline of renal function in patients with Fabry disease who are on long-term biweekly dosing
Raphael Schiffmann et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Sustained, long-term renal stabilization after 54 months of agalsidase β therapy in patients with Fabry disease
Dominique P. Germain et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Fabry disease: Baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry
C. M. Eng et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2007)
The Dutch Fabry cohort:: Diversity of clinical manifestations and Gb3 levels
A. C. Vedder et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2007)
Agalsidase-beta therapy for advanced Fabry disease - A randomized trial
Maryam Banikazemi et al.
ANNALS OF INTERNAL MEDICINE (2007)
Stroke and brain structural alterations in Fabry disease
Andreas Fellgiebel
CLINICAL THERAPEUTICS (2007)
Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life
Raymond Y. Wang et al.
GENETICS IN MEDICINE (2007)
Enzyme-replacement therapy with agalsidase alfa in children with Fabry disease
Markus Ries et al.
PEDIATRICS (2006)
High incidence of later-onset Fabry disease revealed by newborn screening
Marco Spada et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Comparison of health-related quality of life between heterozygous women with Fabry disease, a healthy control population, and patients with other chronic disease
Natalie Jansen Street et al.
GENETICS IN MEDICINE (2006)
The pattern of inheritance of X-linked traits is not dominant or recessive, just X-linked
WB Dobyns
ACTA PAEDIATRICA (2006)
Natural history of Fabry disease in females in the Fabry outcome survey
PB Deegan et al.
JOURNAL OF MEDICAL GENETICS (2006)
Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion setting
R Schiffmann et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Clinical manifestations of Fabry disease in children: Data from the Fabry outcome survey
U Ramaswami et al.
ACTA PAEDIATRICA (2006)
Prevalence of Fabry disease in patients with cryptogenic stroke:: a prospective study
A Rolfs et al.
LANCET (2005)
Ultrastructural study of renal involvement in two females with Anderson-Fabry disease
A Tosoni et al.
ULTRASTRUCTURAL PATHOLOGY (2005)
The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy
C Whybra et al.
CLINICAL GENETICS (2004)
Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey
A Mehta et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2004)
Fabry disease: overall effects of agalsidase alfa treatment
M Beck et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2004)
Clinical presentation in female patients with Fabry disease
N Guffon
JOURNAL OF MEDICAL GENETICS (2003)
Functional class in patients with heart failure is associated with the development of diabetes
A Tenenbaum et al.
AMERICAN JOURNAL OF MEDICINE (2003)
The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents
M Ries et al.
EUROPEAN JOURNAL OF PEDIATRICS (2003)
Enzyme replacement therapy in heterozygous females with Fabry disease: Results of a phase IIIB study
F Baehner et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2003)
Nondiabetic kidney disease
AS Levey
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Cardiac manifestations of Anderson-Fabry disease in heterozygous females
C Kampmann et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
The heart in Anderson Fabry disease
C Kampmann et al.
ZEITSCHRIFT FUR KARDIOLOGIE (2002)
Quality of life of patients with Fabry disease
KF Gold et al.
QUALITY OF LIFE RESEARCH (2002)
Assessment of health-related quality-of-life in males with Anderson Fabry Disease before therapeutic intervention
AH Miners et al.
QUALITY OF LIFE RESEARCH (2002)
Anderson-Fabry disease:: Clinical manifestations of disease in female heterozygotes
C Whybra et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2001)
Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males
KD MacDermot et al.
JOURNAL OF MEDICAL GENETICS (2001)
Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females
KD MacDermot et al.
JOURNAL OF MEDICAL GENETICS (2001)
Neuropathic pain in Anderson-Fabry disease: pathology and therapeutic options
J MacDermot et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Enzyme replacement therapy in Fabry disease - A randomized controlled trial
R Schiffmann et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Infusion of α-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease
R Schiffmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
